Internalized Stigma in Patients With Bipolar Disorder or Schizophrenia

Stigma Clinical Trial

— ESTINT  

Official title:

Internalized Stigma in a Sample of Young Adults With Bipolar Disorder or Schizophrenia.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01664884
• Other study ID #: ESTINT
• Status: Recruiting
• Phase: N/A
• First received: August 10, 2012
• Last updated: August 15, 2012
• Start date: June 2012
• Est. completion date: January 2013

Study information

• Verified date: August 2012
• Source: University of Sao Paulo
• Contact: Luis Felipe Oliveira Costa, M.D.
• Phone: +551198053654
• Email: luis[@]costa.med.br
• Is FDA regulated: No
• Health authority: Brazil: National Committee of Ethics in Research
• Study type: Observational

Clinical Trial Summary

The aim of this study is to explore the levels of internalized stigma in a sample of young patients with bipolar disorder or schizophrenia.

Description:

The stigma is considered by patients, government organizations and health professionals a key point in mental illness (Griffiths et al, 2006). The related literature has focused on individuals with schizophrenia although there are indications that stigma act negatively in patients with bipolar disorder; this, in turn, is described in a few studies, always with heterogeneous samples, chronic and symptomatic patients (Perlick et al, 2001). It is also known that there is a significant association between affective symptoms and the presence of stigma, (Vázquez et al, 2010).

There are reports of higher levels of public stigma towards people with schizophrenia, compared to patients with bipolar disorder or unipolar depression, however there are no studies available on internalized stigma in such samples, especially in remitted patients . Since schizophrenia coexists with significant impairment of insight, such individuals may exhibit more difficulty internalizing the external bias and stereotypes. On the other hand, patients with bipolar disorder - despite being less discriminated by the public in relation to schizophrenia - probably have a high potential for self-stigma and its fearsome consequences, justified by higher levels of insight.

The investigators would like to examine whether the lower impairment of insight in young bipolar patients(in relation to young people with schizophrenia) could be accompanied by an increase in internalized stigma in this sample. It´s an observational, cross-sectional study with no intervention.

Hypothesis: the internalized stigma in young adults with bipolar disorder is identical to that of young patients with schizophrenia.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. completion date: January 2013
• Est. primary completion date: January 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Diagnosis of bipolar disorder and schizophrenia according to DSM-IV-TR, presenting in euthymia (bipolar disorder) or without positive symptoms (schizophrenia), based on clinical assessment and confirmed by structured clinical interview SCID-P

• Age between 18 and 40 years

• Literate and able to understand the tasks required.

• Residents of Greater Sao Paulo.

• Patients and / or legal representatives must understand the nature of the study and sign an informed consent.

Exclusion Criteria:

• Patients with Schizoaffective Disorder or Mental Retardation.

• Unstable serious diseases including kidney disease, gastroenterology, respiratory, cardiovascular, endocrine, neurological, immunological or haematological.

Study Design

Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Bipolar Disorder
• Schizophrenia
• Stigma

Locations

Country	Name	City	State
Brazil	PROGRUDA-Institute of Psychiatry- HCFMUSP	Sao Paulo	SP

Sponsors (1)

Lead Sponsor	Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil,